Laddar...
Identification of favorable subgroups for alternative anti-androgen therapy in castration-resistant prostate cancer
Although alternative anti-androgen therapy (switching to secondary anti-androgens) is no longer recommended in the clinical guidelines of prostate cancer in light of the new hormonal and cytotoxic agents available, this therapy has proven beneficial for some patients with castration-resistant prosta...
Sparad:
| I publikationen: | Mol Clin Oncol |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
D.A. Spandidos
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6787950/ https://ncbi.nlm.nih.gov/pubmed/31620284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1915 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|